Plasma sialyltransferase levels in psychiatric disorders as a possible indicator of HPA axis function

Biological Psychiatry

Volumn 41, Issue 11, 1997, Pages 1131-1136

  Maguire, Teresa M ^a   Thakore, Jogin ^b   Dinan, Timothy G ^b   Hopwood, Sylvia ^c   Breen, Kieran C ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

cortisol; depression; glycosylation; HPA axis; schizophrenia; Sialyltransferase

Indexed keywords

BIOCHEMICAL MARKER; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; ISOENZYME; SIALYLTRANSFERASE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

BINDING SITES; DEPRESSION; GLYCOSYLATION; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LYMPHOCYTES; PITUITARY-ADRENAL SYSTEM; PLASMA; RECEPTORS, GLUCOCORTICOID; SCHIZOPHRENIA; SIALYLTRANSFERASES;

EID: 0030897689     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00223-5     Document Type: Article

References (22)

1. Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB (1987): CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am J Psychiatry 144:873-877.
2. Barbeau D, Liang JJ, Robitialle Y, Quirion R, Srivastava LK (1995): Decreased expression of the embryonic form of the neural cell-adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 92:2785-2789.
3. Breen KC, Regan CM (1986): Synaptosomal sialyltransferase glycosylates surface proteins that are inaccessible to the action of membrane-bound sialidase. J Neurochem 47:1176-1180.
4. Carroll BJ, Martin FI, Davis BM (1968): Resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness. BMJ 3:285-287.
5. Coughlan CM, Seckl JR, Fox DJ, Unsworth R, Breen KC (1996): The corticosteroid regulation of sialyltransferase activities in the rat in vivo is tissue specific. Glycobiology 6:431-436.
6. Cupps TR, Fauci AS (1982): Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133-155.
7. Dinan T (1994): Glucocorticoids and genesis of depressive illness. Br J Psychiatry 164:365-371.
8. Eckhardt M, Muhlenhoff M, Bethe A, Koopman J, Frosch M, Gerardy-Schahn R (1995): Molecular characterisation of eukaryotic polysislyltransferase-1. Nature 373:715-718.
9. Johnstone A, Thorpe R (1987): Immunochemistry in Practice. London: Blackwell Scientific Publications.
10. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Goldstein J, Brasseur M, Copinski G, van Cauter E (1987): 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: Effect of antidepressant treatment. J Clin Endocrinol Metab 65:141-152.
11. Livingston BD, De Robertis EM, Paulson JC (1990): Expression of β-galactoside α2,6 sialyltransferase blocks synthesis of polysialic acid in Xenopus embryos. Glycobiology 1:39-44.
12. Livingston BD, Paulson JC (1993): Polymerase chain reaction cloning of a developmentally regulated member of the sialyltransferase gene family. J Biol Chem 268:11504-11507.
13. Lowy MT (1989): Quantification of type I and II adrenal steroid receptors in neuronal, lymphoid and pituitary tissues. Brain Res 503:191-197.
14. Maguire TM, Breen KC (1995): A decrease in neural sialyltransferase activity in Alzheimer's disease. Dementia 6:185-190.
15. Maguire TM, Gillian AM, O'Mahony D, Coughlan CM, Dennihan A, Breen KC (1994a): A decrease in serum sialyltransferase levels in Alzheimer's disease. Neurobiol Aging 15:99-102.
16. Maguire TM, O'Mahony D, Gillian AM, Dennihan A, Breen KC (1994b): The serum expression of sialoglycoproteins and sialyltransferase in Alzheimer's disease: Evidence for altered expression of individual isoforms. Neurodegeneration 3:129-133.
17. Murburg MM, Paly D, Wilkinson CW, Veith RC, Malas KL, Dorsa DM (1986): Haloperidol increases plasma beta endorphin-like immunoreactivity and cortisol in normal human males. Life Sci 39:373-381.
18. Naber D, Albus M, Burke H, Muller-Spahn F, Munch U, Reinertshofer T, Wissmann J, Ackenheil M (1985): Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psycopathology. Psychiatry Res 16:207-219.
19. Raskind M, Peskind E, Rivard MF, Veith R, Barnes R (1982): Dexamethasone suppression test and cortisol circadian rhythym in primary degenerative dementia. Am J Psychiatry 139:1468-1470.
20. Waddington JL (1993): Schizophrenia: developmental neuroscience and pathophysiology. Lancet 341:531-536.
21. Wang XC, O'Hanlon TP, Lau JTY (1989): Regulation of β-galactoside α2,6-sialyltransferase gene expression by dexamethasone. J Biol Chem 264:1854-1859.
22. Yehuda R, Boisoneau D, Mason JW, Giller EL (1993): Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders. Biol Psychiatry 34:18-25.